Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy

Vascular and Endovascular Surgery

Volumn 41, Issue 6, 2008, Pages 516-521

  Taurino, Maurizio ^a   Raffa, Salvatore ^a   Mastroddi, Massimo ^a   Visco, Vincenzo ^a   Rizzo, Luigi ^a   Torrisi, Maria Rosaria ^a   Faraglia, Vittorio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Carotid plaque; Metalloproteinase; MMP 9; Thromboendarterectomy

Indexed keywords

ENZYME ANTIBODY; GELATINASE A; GELATINASE B; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AGED; ANTIBODY SPECIFICITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN DAMAGE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; NEUROIMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; TISSUE SECTION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; ENDARTERECTOMY, CAROTID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 37249083624     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574407307405     Document Type: Article

References (20)

1. Broderick J., Brott T., Kothari R., et al. The greater Cincinnati/Northern Kentucky stroke study: preliminary first ever and total incidence rates of stroke among blacks. Stroke. 1998 ; 29: 415-421.
2. La mortalità per cause nelle regioni italiane 1998-2000. ISTAT 2002.
3. Loftus IM, Naylor AR, Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption. Stroke. 2000 ; 31: 40-47.
4. Carr SC, Farb A., Pearce WH, Virmani R., Yao JS Activated inflammatory cells are associated with plaque rupture in carotid artery stenosis. Surgery. 1997 ; 122: 757-763.
5. Brown DL, Hibbs MS, Kearney M., Loushin C., Isner JM Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation. 1995 ; 91: 2125-2131.
6. Tziakas DN, Lazarides MK, Tentes IK, et al. Gelatinases [matrix metalloproteinase-2 (MMP-2) and MMP-9] induce carotid plaque instability but their systemic levels are not predictive of local events. Ann Vasc Surg. 2005 ; 19: 529-533.
7. Loftus IM, Naylor AR, Bell Prf, Thompson MM Plasma MMP-9-a marker of carotid plaque instability. Eur J Vasc Endovasc Surg. 2001 ; 21: 17-21.
8. Corrado E., Novo S. Carotidopatia e infiammazione [in Italian]. Minerva Cardioangiol. 2005 ; 53: 89-91.
9. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998 ; 32: 368-372.
10. Higashikata T., Yamagishi M., Higashi T., et al. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis. 2005 ; 185: 165-172.
11. Verhoeven B., Hellings WE, Moll FL, et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg. 2005 ; 42: 1077-1081.
12. Van Oostrom O, Velema E., Schoneveld AH, et al. Age-related changes in plaque composition. A study in patients suffering from carotid artery stenosis. Cardiovasc Pathol. 2005 ; 14: 126-134.
13. Blankenberg S., Rupprecht HJ, Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003 ; 107: 1579-1585.
14. Nascet Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 ; 325: 445-453.
15. Reigner B., Reveilleau P., Gayral M., Papon X., Enon B., Chevalier JM Eversion endarterectomy of the internal carotid artery: midterm results of a new technique. Ann Vasc Surg. 1995 ; 9: 241-246.
16. Alvarez B., Ruiz C., Chacòn P., Alvarez-Sabin J., Matas M. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg. 2004 ; 40: 469-475.
17. Molloy KJ, Thompson MM, Schwalbe EC, Bell Prf, Naylor AR, Loftus IM Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. Eur J Vasc Endovasc Surg. 2004 ; 27: 409-413.
18. Sapienza P., di Marzo L., Borrelli V., et al. Metalloproteinases and their inhibitors are markers of plaque instability. Surgery. 2005 ; 137: 355-363.
19. Clark AW, Krekoski CA, Bou S., Chapman KR, Edwards DR Increased gelatinose A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett. 1997 ; 238: 53-56.
20. Hower CD, Dassow MS, Kajdacsy-Balla A., et al. Metalloproteinase levels are decreased in symptomatic carotid plaques. J Surg Res. 2000 ; 88: 155-159.